Literature DB >> 31474570

The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

Miguel Reina-Campos1, Maria T Diaz-Meco1, Jorge Moscat2.   

Abstract

Atypical protein kinase C (aPKC) isozymes, PKCλ/ι and PKCζ, are now considered fundamental regulators of tumorigenesis. However, the specific separation of functions that determine their different roles in cancer is still being unraveled. Both aPKCs have pleiotropic context-dependent functions that can translate into tumor-promoter or -suppressive functions. Here, we review early and more recent literature to discuss how the different tumor types, and their microenvironments, might account for the selective signaling of each aPKC isotype. This is of clinical relevance because a better understanding of the roles of these kinases is essential for the design of new anti-cancer treatments.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ECT2; Hedgehog; PD-L1; PHGDH; PKCζ; PKCλ/ι; SOX2; atypical PKCs; basal cell carcinoma; cancer; colorectal cancer; immunotherapy; kinase inhibitors; leukemia; lung cancer; metabolism; p62; polarity; prostate cancer; stroma; tumor promoter; tumor suppressor

Mesh:

Substances:

Year:  2019        PMID: 31474570      PMCID: PMC6751000          DOI: 10.1016/j.ccell.2019.07.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  169 in total

Review 1.  The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters.

Authors:  J Moscat; M T Diaz-Meco
Journal:  EMBO Rep       Date:  2000-11       Impact factor: 8.807

Review 2.  Implication of atypical protein kinase C isozymes lambda and zeta in Ras mediated reorganization of the actin cytoskeleton and cyclin D1-induction.

Authors:  K Hellbert; S Kampfer; K Maly; F Hochholdinger; J Mwanjewe; G Baier; F Uberall; H H Grunicke
Journal:  Adv Enzyme Regul       Date:  2000

3.  Unique structural and functional properties of the ATP-binding domain of atypical protein kinase C-iota.

Authors:  M Spitaler; A Villunger; H Grunicke; F Uberall
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

4.  Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway.

Authors:  M Leitges; L Sanz; P Martin; A Duran; U Braun; J F García; F Camacho; M T Diaz-Meco; P D Rennert; J Moscat
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

5.  Requirement of Math1 for secretory cell lineage commitment in the mouse intestine.

Authors:  Q Yang; N A Bermingham; M J Finegold; H Y Zoghbi
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

6.  A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC signalling and cell polarity.

Authors:  D Lin; A S Edwards; J P Fawcett; G Mbamalu; J D Scott; T Pawson
Journal:  Nat Cell Biol       Date:  2000-08       Impact factor: 28.824

7.  Atypical protein kinases Clambda and -zeta associate with the GTP-binding protein Cdc42 and mediate stress fiber loss.

Authors:  M P Coghlan; M M Chou; C L Carpenter
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

8.  Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras.

Authors:  S Kampfer; M Windegger; F Hochholdinger; W Schwaiger; R G Pestell; G Baier; H H Grunicke; F Uberall
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

9.  Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma.

Authors:  A Rácz; N Brass; D Heckel; S Pahl; K Remberger; E Meese
Journal:  Eur J Cancer       Date:  1999-04       Impact factor: 9.162

10.  NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival.

Authors:  Y Lu; L Jamieson; A R Brasier; A P Fields
Journal:  Oncogene       Date:  2001-08-09       Impact factor: 9.867

View more
  26 in total

1.  Protein kinase Cι promotes UBF1-ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells.

Authors:  Verline Justilien; Kayla C Lewis; Kayleah M Meneses; Lee Jamieson; Nicole R Murray; Alan P Fields
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

Review 2.  Serrated Colorectal Cancer: The Road Less Travelled?

Authors:  Yuki Nakanishi; Maria T Diaz-Meco; Jorge Moscat
Journal:  Trends Cancer       Date:  2019-10-28

3.  PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression.

Authors:  Yotaro Kudo; Masayuki Sugimoto; Esperanza Arias; Hiroaki Kasashima; Thekla Cordes; Juan F Linares; Angeles Duran; Yuki Nakanishi; Naoko Nakanishi; Antoine L'Hermitte; Alex Campos; Nadia Senni; Tarmo Rooslid; Lewis R Roberts; Ana Maria Cuervo; Christian M Metallo; Michael Karin; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cancer Cell       Date:  2020-06-25       Impact factor: 31.743

Review 4.  PHLPPing the balance: restoration of protein kinase C in cancer.

Authors:  Hannah Tovell; Alexandra C Newton
Journal:  Biochem J       Date:  2021-01-29       Impact factor: 3.857

5.  NeuroD1 promotes tumor cell proliferation and tumorigenesis by directly activating the pentose phosphate pathway in colorectal carcinoma.

Authors:  Zhuolin Li; Yuxin He; Yanjun Li; Juan Li; Hezhao Zhao; Guanbing Song; Makoto Miyagishi; Shourong Wu; Vivi Kasim
Journal:  Oncogene       Date:  2021-10-16       Impact factor: 9.867

6.  Atypical protein kinase C is essential for embryonic vascular development in mice.

Authors:  Zee Chen; Yaoyun Duan; Hong Wang; Huayuan Tang; Shijia Wang; Xinru Wang; Jie Liu; Xi Fang; Kunfu Ouyang
Journal:  Genesis       Date:  2021-02-06       Impact factor: 2.487

7.  PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis.

Authors:  Juan F Linares; Xiao Zhang; Anxo Martinez-Ordoñez; Angeles Duran; Hiroto Kinoshita; Hiroaki Kasashima; Naoko Nakanishi; Yuki Nakanishi; Ryan Carelli; Luca Cappelli; Esperanza Arias; Masakazu Yashiro; Masaichi Ohira; Sanjay Patel; Giorgio Inghirami; Massimo Loda; Ana Maria Cuervo; Maria T Diaz-Meco; Jorge Moscat
Journal:  Mol Cell       Date:  2021-09-23       Impact factor: 17.970

Review 8.  Orchestration of tissue-scale mechanics and fate decisions by polarity signalling.

Authors:  Martim Dias Gomes; Sandra Iden
Journal:  EMBO J       Date:  2021-05-17       Impact factor: 11.598

Review 9.  Equivocal, explicit and emergent actions of PKC isoforms in cancer.

Authors:  Peter J Parker; Sophie J Brown; Veronique Calleja; Probir Chakravarty; Mathias Cobbaut; Mark Linch; Jacqueline J T Marshall; Silvia Martini; Neil Q McDonald; Tanya Soliman; Lisa Watson
Journal:  Nat Rev Cancer       Date:  2020-11-11       Impact factor: 60.716

10.  Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population.

Authors:  Hiroaki Kasashima; Angeles Duran; Anxo Martinez-Ordoñez; Yuki Nakanishi; Hiroto Kinoshita; Juan F Linares; Miguel Reina-Campos; Yotaro Kudo; Antoine L'Hermitte; Masakazu Yashiro; Masaichi Ohira; Fei Bao; Daniele V F Tauriello; Eduard Batlle; Maria T Diaz-Meco; Jorge Moscat
Journal:  Dev Cell       Date:  2020-11-17       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.